Zepatier

Zepatier is a prescription medication combining elbasvir and grazoprevir for oral treatment of chronic hepatitis C. It targets the virus directly to reduce liver infection. This EU-sourced therapy is used under medical supervision for genotype 1 and 4 infections.

Zepatier is used to treat chronic hepatitis C virus (HCV) infections in adults, primarily genotypes 1 and 4. It works by targeting specific proteins the virus needs to replicate, helping reduce the amount of virus in the body. Patients often ask, 'What is Zepatier used for?' to understand its role in managing HCV.

Zepatier helps reduce HCV viral load by interfering with the virus’s ability to multiply. Many patients experience improved liver function markers over time. It is not a cure for all cases but is part of a broader treatment plan for chronic hepatitis C.

Zepatier should be taken exactly as prescribed by a healthcare provider. Patients with severe liver problems or certain other conditions should discuss risks with their doctor. Regular monitoring may be required during treatment to assess liver function and response.

Zepatier can interact with medications that affect liver enzymes, such as certain HIV treatments, statins, or anticonvulsants. Alcohol and herbal supplements like St. John’s Wort may also alter its effectiveness. Always inform your doctor about all medications and supplements you are taking.